Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut

Clinical Infectious Diseases

Volumn 49, Issue 2, 2009, Pages 262-270

  Van Vliet, Michel J ^a   Tissing, Wim J E ^a   Dun, Catharina A J ^a   Meessen, Nico E L ^b   Kamps, Willem A ^a   De Bont, Eveline S J M ^a   Harmsen, Hermie J M ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CANCER CHEMOTHERAPY; DENATURING GRADIENT GEL ELECTROPHORESIS; FLUORESCENCE IN SITU HYBRIDIZATION; INTESTINE INFECTION; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC AGENTS; BACTERIA; BIODIVERSITY; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DNA FINGERPRINTING; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FECES; GASTROINTESTINAL TRACT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; NUCLEIC ACID DENATURATION;

EID: 67651121491     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599346     Document Type: Article

References (42)

1. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Hae- matol 1997;99:580-8.
2. Costa SF, Miceli MH, Anaissie EJ. Mucosa or skin as source of co- agulase-negative staphylococcal bacteraemia? Lancet Infect Dis 2004; 4:278-86.
3. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14:1201-7.
4. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-40.
5. Bodey GP, Rodriguez V, Chang HY, Narboni. Fever and infection in leukemic patients: a study of 494 consecutive patients. Cancer 1978; 41:1610-22.
6. Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000;25:1269-78.
7. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001; 19:2201-5.
8. Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends Microbiol 2008; 16:107-14.
9. van der Waaij D, Berghuis-de Vries JM, Lekkerkerk L. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 1971;69:405-11.
10. van der Waaij D. The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics. Antonie Van Leeu- wenhoek 1984;50:745-61.
11. Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Keefe DM. Faecal microflora and -glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats. Cancer Biol Ther 2008; 7:1919-25.
12. Von Bultzingslowen I, Adlerberth I, Wold AE, Dahlen G, Jontell M. Oral and intestinal microflora in 5-fluorouracil treated rats, translo- cation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 2003; 18:278-84.
13. Muyzer G, Dewaal EC, Uitterlinden AG. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis ofpoly- merase chain reaction-amplified genes coding for 16S ribosomal RNA. Appl Environ Microbiol 1993; 59:695-700.
14. Muyzer G. DGGE/TGGE a method for identifying genes from natural ecosystems. Curr Opin Microbiol 1999;2:317-22.
15. Gibson BES, Wheatley K, Hann IM, et al. Treatment strategy and long- term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19:2130-8.
16. Harmsen HJ, Raangs GC, He T, Degener JE, Welling GW. Extensive set of 16S rRNA-based probes for detection ofbacteria in human feces. Appl Environ Microbiol 2002; 68:2982-90.
17. Watanabe K, Kodama Y, Harayama S. Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting. J Microbiol Methods 2001; 44:253-62.
18. Sanguinetti CJ, Dias NE, Simpson AJ. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994; 17:914-21.
19. Jansen GJ, Wildeboer-Veloo AC, Tonk RH, Franks AH, Welling GW. Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria. J Microbiol Methods 1999;37:215-21.
20. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990;56:1919-25.
21. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 1996; 142:1097-106.
22. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64:3336-45.
23. Suau A, Rochet V, Sghir A, et al. Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 2001; 24:139-45.
24. Langendijk PS, Schut F, Jansen GJ, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995;61:3069-75.
25. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun 1994;62: 5191-4.
26. Waar K, Degener JE, van Luyn MJ, Harmsen HJ. Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J Med Microbiol 2005; 54:937-44.
27. Murray P, Baron E, Jorgensen JH, Landry M, Pfaller M. Manual of medical microbiology. 9th ed. Washington, DC: ASM Press, 2007.
28. Bodet CA III, Jorgensen JH, Drutz DJ. Antibacterial activities of an- tineoplastic agents. Antimicrob Agents Chemother 1985; 28:437-9.
29. Calame W, van der Waals R, Douwes-Idema N, Mattie H, van Furth R. Antibacterial effect of etoposide in vitro. Antimicrob Agents Che- mother 1988;32:1456-7.
30. Vetere A, Giuliano M, Pantosti A, Panichi G. In vitro activity ofseveral cytostatic drugs against aerobic and anaerobic intestinal bacteria [in Italian]. Boll Ist Sieroter Milan 1984;63:505-9.
31. National Cancer Institute. Cancer therapy evaluation program. Be-thesda, MD: US National Institutes of Health, 2006. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf. Accessed 8 August 2008.
32. Zoetendal EG, Akkermans AD, de Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998; 64:3854-9.
33. Riley LC, Hann IM, Wheatley K, Stevens RF. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. Br J Haematol 1999; 106:436-44.
34. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008;27:104-19.
35. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002;217:133- 9.
36. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006; 34:534-6.
37. Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008; 14:14-21.
38. Worth LJ, Thursky KA, Seymour JF, Slavin MA. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007; 79:226-33.
39. Schneider SM, Le Gall P, Girard-Pipau F, et al. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr 2000; 39:248-55.
40. Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr 2005; 135: 1896-902.
41. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, Rice LB. Use of denaturing gradient gel electrophoresis for analysis of the stool mi- crobiota of hospitalized patients. J Microbiol Methods 2003; 54:249-56.
42. Wiley JS, Taupin J, Jamieson GP, Snook M, Sawyer WH, Finch LR. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma. J Clin Invest 1985; 75:632-42.